Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers after Acute Kidney Injury: Friend, Foe, or Acquaintance?

被引：5
|
作者：
Coca, Steven G. [1 ]
机构：
[1] Icahn Sch Med Mt Sinai, Dept Med, Div Nephrol, One Gustave Levy Pl,POB 1243, New York, NY 10029 USA
来源：
AMERICAN JOURNAL OF NEPHROLOGY | 2020年 / 51卷 / 04期
关键词：
PROGRESSION; RISK; AKI;
D O I：
10.1159/000505896
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：263 / 265
页数：3
相关论文
共 50 条
  • [21] Effects of Spironolactone in Combination with Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers in Patients with Proteinuria
    Kim, Ha Yeon
    Bae, Eun Hui
    Ma, Seong Kwon
    Kim, Soo Wan
    KIDNEY & BLOOD PRESSURE RESEARCH, 2014, 39 (06) : 573 - 580
  • [22] Is angiotensin-converting enzyme inhibitors/angiotensin receptor blockers therapy protective against prostate cancer?
    Mao, Yeqing
    Xu, Xin
    Wang, Xiao
    Zheng, Xiangyi
    Xie, Liping
    ONCOTARGET, 2016, 7 (06) : 6765 - 6773
  • [23] Combination Use of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Diabetic Kidney Disease
    Stanton, Robert C.
    CURRENT DIABETES REPORTS, 2013, 13 (04) : 567 - 573
  • [24] Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in women of childbearing age: risks versus benefits
    Pucci, Mark
    Sarween, Nadia
    Knox, Ellen
    Lipkin, Graham
    Martin, Una
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2015, 8 (02) : 221 - 231
  • [25] Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on prevention of stroke: Which one is better?
    Xiao, Lin
    Ouyang, Haichun
    Su, Qiwen
    Huang, Yuli
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 223 : 56 - 57
  • [26] Association between bone measures and use of angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers
    Holloway-Kew, Kara L.
    Betson, Amelia G.
    Anderson, Kara B.
    Gaston, James
    Kotowicz, Mark A.
    Liao, Wan-Hui
    Henneberg, Maciej
    Pasco, Julie A.
    ARCHIVES OF OSTEOPOROSIS, 2021, 16 (01)
  • [27] Comparing the effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on renal function decline in diabetes
    Huang, Yunyu
    Haaijer-Ruskamp, Flora M.
    Voorham, Jaco
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2016, 5 (03) : 229 - 237
  • [28] Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers: To Continue or Stop Preoperatively-the Debate Continues
    Rajan, Niraja
    Joshi, Girish P.
    ANESTHESIA AND ANALGESIA, 2024, 138 (04) : 760 - 762
  • [29] Angiotensin-converting enzyme inhibitors/angiotensin receptor blockers therapy and colorectal cancer: a systematic review and meta-analysis
    Dai, Yi-Ning
    Wang, Jing-Hua
    Zhu, Jin-Zhou
    Lin, Jie-Qiong
    Yu, Chao-Hui
    Li, You-Ming
    CANCER CAUSES & CONTROL, 2015, 26 (09) : 1245 - 1255
  • [30] Impact of angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers on clinical outcomes in hypertensive patients with acute myocardial infarction
    Lee, Jae-Geun
    Joo, Seung-Jae
    Kim, Song-Yi
    Choi, Joon-Hyouk
    Boo, Ki Yung
    Hwang, Jin-Yong
    Hur, Seung-Ho
    Jeong, Myung Ho
    PLOS ONE, 2023, 18 (03):
12345